Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Valantine Hannah
Director at CareDx · Director at BridgeBio Pharma. Filing since 28 Dec 2021.
CIK 0001855608
CDNA
CareDx, Inc.
Director · 3 trades
BBIO
BridgeBio Pharma, Inc.
Director · 15 trades
Company
Date
Role
Action
Shares
Amount
Of holding
CDNA
CareDx, Inc.
16 Jul 2026
Director
Sold on a plan
28,779
$1.04M
44.0%
BBIO
BridgeBio Pharma, Inc.
23 Jun 2026
Director
Sold on a plan
2,196
$150.58K
19.2%
BBIO
BridgeBio Pharma, Inc.
22 Jun 2026
Director
Sold on a plan
2,808
$190.94K
19.7%
CDNA
CareDx, Inc.
15 Jun 2026
Director
Sold on a plan
12,103
$279.73K
24.8%
BBIO
BridgeBio Pharma, Inc.
10 Mar 2026
Director
Sold on a plan
8,671
$624.31K
53.7%
BBIO
BridgeBio Pharma, Inc.
27 Feb 2026
Director
Sold on a plan
25,484
$1.72M
77.3%
BBIO
BridgeBio Pharma, Inc.
12 Nov 2025
Director
Sold at will
25,484
$1.68M
77.3%
BBIO
BridgeBio Pharma, Inc.
26 Jun 2025
Director
Sold at will
2,418
$106.50K
24.5%
BBIO
BridgeBio Pharma, Inc.
26 Jun 2025
Director
Sold at will
2,289
$100.82K
85.2%
CDNA
CareDx, Inc.
18 Jun 2025
Director
Sold on a plan
10,570
$202.57K
21.3%
BBIO
BridgeBio Pharma, Inc.
10 Jun 2025
Director
Sold on a plan
4,292
$171.68K
70.9%
BBIO
BridgeBio Pharma, Inc.
6 Mar 2025
Director
Sold on a plan
12,875
$419.50K
88.0%
BBIO
BridgeBio Pharma, Inc.
15 Feb 2024
Director
Sold on a plan
2,915
$110.04K
62.3%
BBIO
BridgeBio Pharma, Inc.
16 Jan 2024
Director
Sold on a plan
2,915
$110.68K
62.3%
BBIO
BridgeBio Pharma, Inc.
15 Dec 2023
Director
Sold on a plan
2,915
$105.29K
62.3%
BBIO
BridgeBio Pharma, Inc.
15 Nov 2023
Director
Sold on a plan
2,915
$87.45K
62.3%
BBIO
BridgeBio Pharma, Inc.
29 Dec 2021
Director
Bought
1,764
$25.10K
opened
BBIO
BridgeBio Pharma, Inc.
28 Dec 2021
Director
Bought
3,433
$44.48K
opened
18 decisions on file.
